Equities research analysts at Wedbush raised their Q1 2025 earnings per share (EPS) estimates for Fate Therapeutics in a ...

Equities research analysts at Roth Capital cut their Q1 2025 EPS estimates for shares of ARQ in a research report issued to clients and investors on Wednesday, March 5th. Roth Capital analyst G.

By Andreas Charalambous, Omiros Pissarides, and Evangelos Tryfonos Preventive risk management is of paramount importance, as ...

We tested 8 highly-rated moka pots on the market and found two of the best so you can enjoy rich, full-bodied coffee for less ...

but the newly introduced Ohio Senate Bill 1 provides a path to restoring trust. Being over 70 pages long, I can only touch on a few positive dimensions here. Arguably the most pernicious negative ...

According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

ECE professor Kangwook Lee provides insights on new Chinese AI Deepseek, discussing how it was built and what it means for ...

Understand the differences between Tesla vs. BYD in EV battery technology. Discover efficiency, cost, and safety insights.

Though the movie did have a better-than-expected opening weekend (it's already passed the $200 million mark worldwide), the critical reception was mixed-negative ... single one of these movies ...

Researchers from the University of Twente and Utrecht University created ultrathin nanoribbons made of germanium atoms that ...

Find out how negative ionization technology is transforming architecture to create cleaner, more comfortable spaces for ...